Crohn's disease in common variable immunodeficiency: Treatment with antitumor necrosis factor alpha [5]

American Journal of Gastroenterology

Volumn 101, Issue 9, 2006, Pages 2165-2166

  Nos, Pilar ^a   Bastida, Guillermo ^a   Beltran, Belen ^a   Aguas, Mariam ^a   Ponce, Julio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CORTICOSTEROID DERIVATIVE; INFLIXIMAB; METRONIDAZOLE; TUMOR NECROSIS FACTOR ALPHA;

ANAMNESIS; ANUS DISEASE; CLINICAL FEATURE; COLON RESECTION; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPY; HUMAN; ILEORECTAL ANASTOMOSIS; LETTER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SCREENING TEST; SPAIN; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; FOLLOW-UP STUDIES; HUMANS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748349228     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00763_5.x     Document Type: Letter

References (6)

1. Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep 2004;6:377-83.
2. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48.
3. Sarmiento E, Mora R, Rodriguez-Mahou M, et al. Enfermedad autoinmune en inmunodeficiencias primarias de anticuerpos (in spanish). Allergol Immunopathol 2005;33:69-73.
4. Aukrust P, Lien E, Kristoffersen AK, et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency. Possible immunologic and clinical consequences. Blood 1996;87:674-81.
5. Crum NF, Lederman ER, Wallance MR. Infections associated with tumor necrosis factor-α antagonists. Medicine 2005;84:291-300.
6. Smith KJ, Skelton H. Common variable immunodeficiency treated with a recombinant human IgG, tumor necrosis factor-α receptor fusion protein. Br J Dermatol 2001;144:597-600.